The chief executive of Pfizer has said US President Donald Trump should use trade deals to fight price controls on medicines in other countries.
Albert Bourla told a US Senate hearing that other nations are "free-riding on American innovation".
His proposal was one of several put forward by the pharmaceutical industry at a hearing in Washington where firms were grilled about high US drug costs.
Senators told the companies the current pricing system is "unacceptable".
